[Vaccination of the very premature infant]

Arch Pediatr. 2002 Sep:9 Suppl 4:431s-434s. doi: 10.1016/s0929-693x(03)00249-5.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents / administration & dosage
  • Humans
  • Immune System / growth & development
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Palivizumab
  • Risk Factors
  • Vaccination* / adverse effects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Palivizumab